Earnings Preview: Sangamo Therapeutics (SGMO) Q4 Earnings Expected to DeclineZacks Investment Research • 02/20/20
Sangamo Therapeutics (SGMO) Looks Good: Stock Adds 6.4% in SessionZacks Investment Research • 12/04/19
Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/07/19
Sangamo Therapeutics (SGMO) CEO Sandy Macrae on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/13/19
Sangamo's Hemophilia A Results Light A Spark And Push Program Into Pfizer's HandsSeeking Alpha • 07/17/19
Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study (Revised)Zacks Investment Research • 07/11/19
Gene Therapy Battle: Why Sangamo Therapeutics Is Thrashing Its RivalsInvestors Business Daily • 07/08/19
Sangamo Therapeutics, Inc.: Upcoming News And Q2 Results Will Send The Stock SoaringSeeking Alpha • 07/02/19